企業プロフィール
Salarius Pharmaceuticals 株価・ニュース・カタリスト
- ティッカー:
- SLRX
- 取引所:
- NASDAQ
- セクター:
- Biopharma
- 所在地:
- United States
株価変動の要因
Current closing-price context is not available for SLRX.
企業概要
事業概要
Salarius Pharmaceuticals is a biotechnology company focused on oncology and epigenetic or related cancer biology. Its story is built around seeking targeted cancer therapies for difficult tumors.
所在地とセクター分類
Salarius is headquartered in the United States and listed on NASDAQ. It sits in small-cap oncology biotechnology.
ビジネスモデルの特徴
The company depends on clinical data, partnership options, and capital discipline. Investors usually track early readouts and whether the pipeline can maintain enough momentum to matter.
バイオ業界での位置付け
Salarius occupies a catalyst-sensitive oncology niche within biotech. The stock is driven by proof-of-concept and the market's confidence in the company's cancer thesis.
今後のカタリスト
- Salarius is a legacy / closeout story now, so the catalysts are any remaining strategic or asset-resolution update rather than a live oncology milestone. The market is mainly focused on residual value.
最近のニュース
- 01
- 02
- 03
- 04
- 05
類似銘柄
事業成熟度、治療領域、カタリスト傾向が近い同業銘柄です。